The weekly litigation news digest is live. Subscribe now

Methods And Compositions For Adoptive Immunotherapy - EP1827604

The patent EP1827604 was granted to Peter Maccallum Cancer Institute on Nov 20, 2019. The application was originally filed on Dec 12, 2005 under application number EP05815888A. The patent is currently recorded with a legal status of "Revoked".

EP1827604

PETER MACCALLUM CANCER INSTITUTE
Application Number
EP05815888A
Filing Date
Dec 12, 2005
Status
Revoked
Jul 14, 2023
Publication Date
Nov 20, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREAug 20, 2020KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE
PATENT BOUTIQUEAug 20, 2020BRISCOEADMISSIBLE
GLAXOSMITHKLINEAug 19, 2020OFARRELLADMISSIBLE

Patent Citations (2) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO0023573
OPPOSITIONWO02077029

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents